CAPILLARY

Capillary Technologies India Financial Results

₹583.50-0.63%
Market cap
₹4,633 crore
P/E
110.1
P/B
4.53
ROE
6.6%
Dividend yield
1.20%

For the year ended Mar 2023, Capillary Technologies India reported revenue of ₹255 crore and net profit of -₹88 crore, against ₹525 crore and -₹59 crore a year earlier.

Capillary Technologies India annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Capillary Technologies India annual profit and loss (₹ crore)
ItemMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue255525598735811
Expenses321531532636696
Operating profit-65-66699116
Operating margin %-26%-1%11%13%14%
Other income18412329
Interest1017745
Depreciation3756607578
Profit before tax-95-75115142
Tax %7%9%-33%-3%0%
Net profit-88-59135242
EPS (₹)-11.06-7.491.676.605.30
Dividend payout %—————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Capillary Technologies India financial results — frequently asked questions

What is Capillary Technologies India's annual revenue and net profit?

For the financial year ended Mar 2023, Capillary Technologies India's revenue was ₹255 crore and net profit -₹88 crore; net profit fell 49.15% from -₹59 crore in Mar 2024.

How fast has Capillary Technologies India grown over three years?

From Mar 2026 to Mar 2023, Capillary Technologies India's revenue grew at a compound annual rate of -29.7%. Past growth does not indicate future results.

What is the EPS of Capillary Technologies India?

Annual EPS for Mar 2023 was -₹11.06.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Capillary Technologies India With ATS

Track CAPILLARY live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.